Towards Mechanism-Based Therapies in Arrhythmogenic Cardiomyopathy.
作者信息
Saffitz Jeffrey E
机构信息
Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
出版信息
JACC Basic Transl Sci. 2025 Aug;10(8):101313. doi: 10.1016/j.jacbts.2025.05.008.
Abstract
摘要
相似文献
1
Towards Mechanism-Based Therapies in Arrhythmogenic Cardiomyopathy.致心律失常性心肌病基于机制的治疗方法
JACC Basic Transl Sci. 2025 Aug;10(8):101313. doi: 10.1016/j.jacbts.2025.05.008.
2
Evaluation of Tideglusib as a Disease Modifying Therapy in Murine Models of Arrhythmogenic Cardiomyopathy.在致心律失常性心肌病小鼠模型中评估替德格鲁西作为疾病修饰疗法的效果。
JACC Basic Transl Sci. 2025 Aug;10(8):101281. doi: 10.1016/j.jacbts.2025.03.013.
3
In vitro analysis of arrhythmogenic cardiomyopathy associated desmoglein-2 (DSG2) mutations reveals diverse glycosylation patterns.体外分析心律失常性心肌病相关桥粒芯糖蛋白-2（DSG2）突变揭示了不同的糖基化模式。
J Mol Cell Cardiol. 2019 Apr;129:303-313. doi: 10.1016/j.yjmcc.2019.03.014. Epub 2019 Mar 15.
4
Myocarditis-like Episodes in Patients with Arrhythmogenic Cardiomyopathy: A Systematic Review on the So-Called Hot-Phase of the Disease.致心律失常性右室心肌病患者的心肌炎样发作：疾病“热相”的系统综述。
Biomolecules. 2022 Sep 19;12(9):1324. doi: 10.3390/biom12091324.
5
Disease Progression in Exercise-Induced Arrhythmogenic Cardiomyopathy Compared With Arrhythmogenic Right Ventricular Cardiomyopathy.与致心律失常性右心室心肌病相比，运动诱发的致心律失常性心肌病的疾病进展
JACC Cardiovasc Imaging. 2025 Aug;18(8):853-863. doi: 10.1016/j.jcmg.2025.03.018. Epub 2025 Jul 9.
6
High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy/dysplasia.心律失常性右室心肌病/发育不良中与桥粒芯糖蛋白-2 突变相比，桥粒斑蛋白-2 突变与心力衰竭风险增加相关。
Eur J Heart Fail. 2019 Jun;21(6):792-800. doi: 10.1002/ejhf.1423. Epub 2019 Feb 21.
7
Cardiac sympathetic neurons are additional cells affected in genetically determined arrhythmogenic cardiomyopathy.心脏交感神经元是遗传性致心律失常性心肌病中受影响的其他细胞。
J Physiol. 2025 Mar;603(7):1959-1982. doi: 10.1113/JP286845. Epub 2024 Aug 14.
8
A Rare Desmoglein-2 Gene Mutation in Arrhythmogenic Right Ventricular Cardiomyopathy Inciting Incessant Ventricular Fibrillation.致心律失常性右室心肌病中一种罕见的桥粒芯糖蛋白-2基因突变引发持续性室颤
Cureus. 2018 Sep 29;10(9):e3388. doi: 10.7759/cureus.3388.
9
Characteristics of Patients With Arrhythmogenic Left Ventricular Cardiomyopathy: Combining Genetic and Histopathologic Findings.心律失常性左室心肌病患者的特征：结合遗传学和组织病理学发现。
Circ Arrhythm Electrophysiol. 2020 Dec;13(12):e009005. doi: 10.1161/CIRCEP.120.009005. Epub 2020 Dec 15.
10
Genetic Animal Models for Arrhythmogenic Cardiomyopathy.致心律失常性心肌病的遗传动物模型
Front Physiol. 2020 Jun 24;11:624. doi: 10.3389/fphys.2020.00624. eCollection 2020.
本文引用的文献
1
Evaluation of Tideglusib as a Disease Modifying Therapy in Murine Models of Arrhythmogenic Cardiomyopathy.在致心律失常性心肌病小鼠模型中评估替德格鲁西作为疾病修饰疗法的效果。
JACC Basic Transl Sci. 2025 Aug;10(8):101281. doi: 10.1016/j.jacbts.2025.03.013.
2
NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy.在致心律失常性心肌病的临床前模型中，核因子κB信号通路通过CCR2 +巨噬细胞驱动心肌损伤。
J Clin Invest. 2024 Jul 1;134(13):e183441. doi: 10.1172/JCI183441.
3
Tideglusib Ameliorates Ischemia/Reperfusion Damage by Inhibiting GSK-3β and Apoptosis in Rat Model of Ischemic Stroke.替格瑞洛通过抑制糖原合成酶激酶-3β及细胞凋亡改善缺血性脑卒中大鼠模型的缺血/再灌注损伤
J Stroke Cerebrovasc Dis. 2022 Apr;31(4):106349. doi: 10.1016/j.jstrokecerebrovasdis.2022.106349. Epub 2022 Feb 10.
4
A Phase 2 Study of AMO-02 (Tideglusib) in Congenital and Childhood-Onset Myotonic Dystrophy Type 1 (DM1).一项 AMO-02（替度鲁肽）治疗先天性和儿童期起病肌强直性营养不良 1 型（DM1）的 2 期研究。
Pediatr Neurol. 2020 Nov;112:84-93. doi: 10.1016/j.pediatrneurol.2020.08.001. Epub 2020 Aug 5.
5
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy.锚蛋白-B 功能障碍可导致心律失常性心肌病，且对此种疾病有治疗作用。
J Clin Invest. 2019 Jul 2;129(8):3171-3184. doi: 10.1172/JCI125538.
6
Arrhythmogenic Right Ventricular Cardiomyopathy.致心律失常性右室心肌病
N Engl J Med. 2017 Jan 5;376(1):61-72. doi: 10.1056/NEJMra1509267.
7
Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy.糖原合成酶激酶3β在致心律失常性心肌病发病机制中的核心作用。
JCI Insight. 2016 Apr 21;1(5). doi: 10.1172/jci.insight.85923.
8
Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy.在致心律失常性心肌病斑马鱼模型中鉴定一种新的闰盘调节剂。
Sci Transl Med. 2014 Jun 11;6(240):240ra74. doi: 10.1126/scitranslmed.3008008.
9
A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.一种用于诊断致心律失常性右室心肌病的新型检测方法。
N Engl J Med. 2009 Mar 12;360(11):1075-84. doi: 10.1056/NEJMoa0808138.
10
Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.核内桥粒斑珠蛋白对经典Wnt/β-连环蛋白信号通路的抑制重现了致心律失常性右室心肌病的表型。
J Clin Invest. 2006 Jul;116(7):2012-21. doi: 10.1172/JCI27751.
Zotero 插件